Evidence map›Paper›PMID 12676841›Full record

ArticleBMJ (Clinical research ed.)2003

Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening.

Joël Coste, Béatrix Cochand-Priollet, Patricia de Cremoux, Catherine Le Galès, Isabelle Cartier, Vincent Molinié, Sylvain Labbé, Marie-Cécile Vacher-Lavenu, Philippe Vielh, French Society of Clinical Cytology Study Group

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in BMJ (Clinical research ed.), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 7 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 7 syntheses or guidelines pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. The Korean guideline for cervical cancer screening.Journal of gynecologic oncology · 2015
    Guideline
  5. The diagnostic value of serum hybrid capture 2 (CH2) HPV DNA in cervical cancer: a systematic review and meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2008
    Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Joël CosteDépartement de Biostatistique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Cochin-Port Royal, Université Paris V, Paris, France. coste@cochin.univ-paris5.fr
Béatrix Cochand-Priollet
Patricia de Cremoux
Catherine Le Galès
Isabelle Cartier
Vincent Molinié
Sylvain Labbé
Marie-Cécile Vacher-Lavenu
Philippe Vielh
French Society of Clinical Cytology Study Group
Institut Curie · FRCentre Hospitalier Universitaire de Besançon · FRHôpital Cochin · FRHôpital Foch · FRHôpital Lariboisière · FRHôpital Privé Jacques Cartier · FRInserm · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare the sensitivity, specificity, and interobserver reliability of conventional cervical smear tests, monolayer cytology, and human papillomavirus testing for screening for cervical cancer.

designCross sectional study in which the three techniques were performed simultaneously with a reference standard (colposcopy and histology).

settingPublic university and private practices in France, with complete independence from the suppliers.

participants828 women referred for colposcopy because of previously detected cytological abnormalities and 1757 women attending for routine smears.

main outcome measuresClinical readings and optimised interpretation (two blind readings followed, if necessary, by consensus). Sensitivity, specificity, and weighted kappa computed for various thresholds of abnormalities.

resultsConventional cervical smear tests were more often satisfactory (91% v 87%) according to the Bethesda system, more reliable (weighted kappa 0.70 v 0.57), and had consistently better sensitivity and specificity than monolayer cytology. These findings applied to clinical readings and optimised interpretations, low and high grade lesions, and populations with low and high incidence of abnormalities. Human papillomavirus testing associated with monolayer cytology, whether systematic or for atypical cells of undetermined significance, performed no better than conventional smear tests.

conclusionsMonolayer cytology is less reliable and more likely to give false positive and false negative results than conventional cervical smear tests for screening for cervical cancer.

Indexed as

ColposcopyCross-Sectional StudiesCytodiagnosisDNA, ViralFemaleHumansMass ScreeningObserver VariationPapillomaviridaePapillomavirus InfectionsSensitivity and SpecificityTumor Virus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsVaginal SmearsDNA, Viral

Identifiers

PMID12676841
PMCPMC152633
OpenAlexW1987612488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.